Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine

Investor logo

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

HAMMEROVÁ Jindřiška ULDRIJAN Stjepan TÁBORSKÁ Eva HYRŠLOVÁ VACULOVÁ Alena SLANINOVÁ Iva

Year of publication 2012
Type Article in Periodical
Magazine / Source Biological Chemistry
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.1515/hsz-2011-0279
Field Biochemistry
Keywords apoptosis; Bcl-2; benzophenanthridine alkaloids; LC3; necrostatin-1; RIP1
Attached files
Description We show that the plant quaternary benzo[c]phenanthridine alkaloid sanguilutine (SL) is a strong inducer of caspase-independent non-apoptotic death in human melanoma cells. Necrostatin-1, a specific inhibitor of necroptosis, completely reversed the cytotoxic effect of SL, suggesting that necroptosis was a predominant type of cell death induced by SL in these cells. In addition, we showed that SL can trigger an autophagic response, as confirmed by GFP-LC3 puncta formation and LC3-II accumulation. Interestingly, we observed a significant decrease in the viability of melanoma cells treated with combination of autophagy inhibitors (3-methyladenine, bafilomycin-A1 and LY294002) and SL. Our results further indicated that autophagy may serve as a pro-survival mechanism, delaying the induction of necroptosis in melanoma cells. The ability of SL to induce caspase-independent non-apoptotic cell death (necroptosis) suggests its possible therapeutic potential in the treatment of apoptosis-resistant melanoma tumours. Furthermore, SL might serve as a useful tool for studying the mechanisms of necroptosis and autophagy induction and the interplay between these two processes.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.